Table 1.
Group I (ECMO) | Group II (ECMO + IABP) | P-value | |
---|---|---|---|
Age (years) | 54.2 ± 17.5 | 52.1 ± 16.1 | 0.39 |
Sex | 0.48 | ||
Male | 70 (59.8) | 60 (64.5) | |
Female | 47 (40.2) | 33 (35.5) | |
BMI (Kg/m2) | 26.4 ± 3.2 | 27.5 ± 3.2 | 0.02* |
Primary diagnosis | 0.25 | ||
CMP | 23 (19.7) | 26 (30.0) | |
CAD | 34 (29.1) | 26 (28.0) | |
CTEPH | 19 (16.2) | 5 (5.4) | |
Aortic pathology | 11 (9.4) | 8 (8.6) | |
Valvular pathology | 14 (12.0) | 12 (12.9) | |
Combined cardiac pathology | 15 (12.8) | 14 (15.1) | |
IE | 1 (0.9) | 2 (2.2) | |
Preop. EF (%) | 50 (35-60) | 40 (25-55) | 0.12 |
Cannulation site | |||
Central# | 53 (45.3) | 27 (29.0) | 0.016* |
Femoral vein-femoral artery | 54 (46.2) | 40 (43.0) | 0.64 |
Femoral vein-axillary artery | 9 (7.7) | 22 (18.8) | 0.001* |
Jugular vein-femoral artery | 1 (0.9) | 4 (4.3) | 0.1 |
Need for ECMO | 0.31 | ||
Cardiomyopathy | 22 (18.8) | 22 (23.6) | |
Acute myocardial infarction | 6 (5.1) | 6 (6.4) | |
Post-cardiotomy syndrome | 81 (69.2) | 61 (65.6) | |
Heart transplantation | 8 (6.8) | 4 (4.3) |
Right atrial venous-aortic arterial cannulation
Statistically significant parameter
BMI=body mass index; CAD=coronary artery disease; CMP=cardiomyopathy; CTEPH=chronic thromboembolic pulmonary hypertension; ECMO=extracorporeal membrane oxygenation; EF=ejection fraction; IABP=intra-aortic balloon pump; IE=infective endocarditis